Insider Transactions in Q3 2023 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2023
|
Garen G Bohlin |
BUY
Open market or private purchase
|
Direct |
41,140
+47.68%
|
$41,140
$1.22 P/Share
|
|
Sep 05
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,622
-0.23%
|
$3,622
$1.33 P/Share
|
|
Sep 01
2023
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
6,913
-2.82%
|
$6,913
$1.33 P/Share
|
|
Sep 01
2023
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,415
-3.51%
|
$7,415
$1.33 P/Share
|
|
Sep 01
2023
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
3,888
-2.66%
|
$3,888
$1.33 P/Share
|
|
Aug 07
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,722
-0.46%
|
$3,722
$1.72 P/Share
|
|
Jul 28
2023
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,845
-1.79%
|
$2,845
$1.7 P/Share
|
|
Jul 05
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,538
-0.44%
|
$3,538
$1.72 P/Share
|